KDIGO Publishes 2022 Diabetes Management in CKD Guideline
|
|
KDIGO has published the 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD). The Guideline and Executive Summary are now available online in Supplement to Kidney International and Kidney International, respectively, and are available on the KDIGO website. The Guideline was co-chaired by Ian de Boer, MD, MS (United States), and Peter Rossing, MD, DMSc (Denmark), who co-chaired the 2020 Guideline. The Work Group for this guideline also served on the 2020 Diabetes in CKD Guideline.
The KDIGO 2022 Diabetes in CKD Guideline follows only two years after the original clinical practice guideline on this topic in 2020. The update was motivated by the wealth of high-quality new information that has quickly become available since the 2020 guideline was published and by calls from the community to help guide the application of these new data.
|
|
“This update to the Diabetes Guideline again emphasizes patient-centeredness and a holistic approach to treatment for patients with diabetes and CKD,” says Dr. de Boer. “Notably, the Work Group included two members with diabetes and CKD who contributed actively as peers to keep the guideline relevant and patient-centered. Incorporating patients as partners has become more common in research, and we are pleased to see that this model is being adopted by additional clinical practice guidelines.”
“As Co-Chairs, we would like to recognize the outstanding efforts of all of these dedicated contributors, without whom this guideline would not have been possible,” said Dr. Rossing. “This Work Group, which included all authors of the 2020 Diabetes Guideline, was diverse, multinational, multidisciplinary, experienced, thoughtful, and vigilant in its work. We hope that the summary guidance provided here will help improve the care of patients with diabetes and CKD worldwide.” Read the full News Release.
|
|
|
KDIGO Announces Morgan Grams as Incoming Co-Chair
|
|
KDIGO has announced its new Co-Chair Elect, Morgan Grams, MD, PhD, MHS. Dr. Grams was elected by the KDIGO Executive Committee and will assume her post in 2023. Dr. Grams is Co-Director of the Division of Precision Medicine, and the Susan and Morris Mark Professor in the Departments of Medicine and Population Health at New York University Langone.
Dr. Grams will join Michel Jadoul, MD, as Co-Chair of KDIGO. She will succeed Wolfgang Winkelmayer, MD, MPH, ScD, who has served in this volunteer role since 2016.
KDIGO Co-Chairs serve as the foundation’s top leaders. They are elected by the KDIGO Executive Committee, devise organizational strategy, prioritization of topics, and ensure the highest quality and clinical utility of KDIGO scientific products.
“KDIGO is a powerful global force in translating evidence-based knowledge to the care of patients with kidney disease,” said Dr. Grams. “I am deeply honored to continue this important work with Dr. Jadoul, Dr. Winkelmayer, and the KDIGO team. Our goal is to improve outcomes for patients worldwide.” Read the full News Release.
|
|
KDIGO 2022 Hepatitis C in CKD Guideline Publishing Soon
|
|
KDIGO will publish its next major guideline this month with the release of the 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Publishing November 18, the Guideline and Executive Summary will be available online in Supplement to Kidney International and Kidney International, respectively, as well as on the KDIGO website.
The 2022 Hepatitis C Guideline is a focused update of the prior guideline published in 2018. KDIGO Co-Chair, Michel Jadoul, MD (Belgium), and Paul Martin, MD (United States) co-chaired the guideline.
|
|
ISN-KDIGO Webinar: Conclusions from the KDIGO Conference on Home Dialysis
November 17, 6:00 PM CET/ 12:00 PM EST
The KDIGO Controversies Conference on Home Dialysis reaffirmed the need for advocacy and efforts to ensure equitable access to home dialysis for all individuals in need of kidney replacement therapy globally. A particular emphasis was on exploring the specific and local factors that impact home dialysis uptake. This webinar will address these factors and effective ways to improve outcomes for patients. Register for the webinar.
|
|
Africa Healthcare Network Fireside Chat Series 105 – KDIGO: Understanding Kidney Impairment and Solid Organ Malignancies
November 17, 7:00 PM East Africa Time (Kenya/Tanzania/Uganda) / 6:00 PM Central Africa Time (Rwanda/Burundi)
Join Professor Jolanta Malyszko, MD, FASN, PhD (Poland), and KDIGO for the next Africa Healthcare Network Fireside Chat, “KDIGO: Understanding Kidney Impairment and Solid Organ Malignancies,” on Thursday, November 17, at 6:00 PM (CET)/ 12:00 PM (EST). Attend the webinar by clicking this direct Zoom webinar link.
|
|
KDIGO 2022 Diabetes in CKD Guideline Top Takeaways for Clinicians and Patients
|
|
KDIGO 2022 Diabetes in CKD Guideline Slide Set
|
|
Plenary Presentations from the KDIGO Role of Complement in CKD Controversies Conference
KDIGO held the Role of Complement in Kidney Diseases Controversies Conference in Florence, Italy, from September 29 to October 2. A global panel of multidisciplinary clinical and scientific expertise and a motivated group of patients and patient advocates convened to define the role of complement in a spectrum of kidney diseases, including glomerular disorders, vasculitides, hemolytic uremic syndrome, and diabetic nephropathy.
|
|
|
|
|
|
|
